Contraception Prescribing Credentialing for Maryland Pharmacists

Contraception Prescribing Credentialing for Maryland Pharmacists

This educational activity has been approved by the Maryland Board of Pharmacy

In the United States, it is estimated that 49% of pregnancies are unintended1. Prevention of unwanted pregnancy has been identified as a public health goal in U.S. Department of Health and Human Services’ Healthy People 2020 Initiative2. The use of oral contraception is a safe and effective strategy for avoiding unwanted pregnancy. However, there are barriers that prevent women desiring contraception from obtaining it, such as knowledge deficits among health care providers and the lack of affordable access3. In 2017 the state of Maryland passed legislation that broadens the scope of pharmacist practice to include hormonal contraceptive prescribing. This regulation broadens access to contraceptive therapy, which in turn will lead to the prevention of unwanted pregnancies.

The University of Maryland School of Pharmacy’s Office of Continuing Education has developed a comprehensive pharmacist training program focused on providing pharmacists with the knowledge and skills necessary to provide contraceptive care to women. This educational program will prepare pharmacists to serve as direct providers of contraceptive treatment pursuant to COMAR 10.34.40 and is catered to the specific processes adopted by the Board of Pharmacy and will enable Maryland’s pharmacists to prescribe contraceptive treatment according to Maryland’s law. 

The training program will include modules covering patient assessment, drug selection, and ongoing therapeutic management of contraceptive therapy as well as the strategies needed to successfully implement this expansion of pharmacy practice.

This four hour, interactive program is offered completely online and is presented as a series of four (4) modules. Each module is ACPE-approved for one contact hour of continuing education credit for a total of 4.0 contact hours of continuing education for pharmacists. At the completion of the full series, pharmacists will be eligible to apply to the Board of Pharmacy for a credential to prescribe contraceptive drugs in their practice.

1 Finer LB, Zolna MR. Unintended pregnancy in the United States: Incidence and disparities, 2006. Contraception. 201;84:478–485.
2 Healthy People 2020 [Internet]. Washington, DC: U.S. Department of Health and Human Services, Office of Disease Prevention and Health Promotion [cited [7/25/2018]]. Available from: [https://www.healthypeople.gov/2020/topics-objectives/topic/family-planning]
3 Leeman L. Medical barriers to effective contraception. Obstet Gynecol Clin North Am 2007;34:19-29.

Modules (UAN, Contact Hours)

  • Hormonal Contraceptive Products (0025-0000-19-002-H01-P, 1.0 CE Contact Hours)
  • Assessing Women for Hormonal Contraception (0025-0000-19-003-H01-P, 1.0 CE Contact Hours)
  • Communicating About Hormonal Contraceptives (0025-00000-19-004-H01-P, 1.0 CE Contact Hours)
  • Pharmacy Practice Operations (0025-0000-19-005-H03-P, 1.0 CE Contact Hours)

Launch Date: 1/1/2019
Expiration Date: 1/1/2021
Course Number: CN#CPCS01
Target Audience: Pharmacists
Instructors:

  • Kristine Parbuoni, PharmD, BCPPS, Associate Professor, Department of Pharmacy, Practice and Science and Director of OSCE Programs, University of Maryland School of Pharmacy
  • Charmaine Rochester-Eyeguokan, PharmD, CDE, BCPS, BCACP, Professor, Department of Pharmacy, Practice and Science and Associate Director, Clinical Services, P3 eHealth Services, University of Maryland School of Pharmacy
  • Katherine Sánchez Vega, PharmD, Clinical Pharmacy Specialist, Women's Health, Veteran Affairs Maryland Health Care System

Learning Objectives

Module 1: Hormonal Contraceptive Products

At the end of this knowledge-based activity, the learner should be able to:

  1. Describe how hormonal contraceptive products affect phases of the menstrual cycle to inhibit ovulation;
  2. Compare and contrast the pharmacology, efficacy, clinical use, and roles in therapy of the available types of hormonal contraception, including long acting reversible contraception, barrier methods, and other hormonal contraception;
  3. Identify patient-related variables that may influence the use of contraception; and
  4. List non-contraceptive uses of various forms of hormonal contraceptive products, including but not limited to menstrual bleeding, dysmenorrhea, premenstrual dysphoric disorder symptoms, menstrual migraines, ovarian cysts, and acne.

Module 2: Assessing Women for Hormonal Contraception

At the completion of this application-based activity, the learner should be able to:

  1. Given a patient case, including medication and medical history, and using the Maryland Self Screening Risk Assessment for Birth Control, evaluate a patient to rule out pregnancy and determine appropriateness for potential contraceptive use;
  2. Given a patient case and using the United States Medical Eligibility Criteria (US MEC) and the Maryland Algorithm for hormonal contraception, assess whether a screened patient is an appropriate or at-risk candidate for hormonal contraceptives; and
  3. Select the most appropriate hormonal contraceptive product based on patient- and agent-related variables.

Module 3: Communicating About Hormonal Contraceptives

At the completion of this application-based activity, the learner should be able to:

  1. Formulate a plan to educate women on proper use of all the types of hormonal contraceptive products, including but not limited to when to start, missed doses, back-up methods, and adherence;
  2. Formulate a plan to educate women on the risks and benefits of hormonal contraceptive products, including but not limited to warning signs, adverse events, and when to call 911;
  3. List counseling strategies to reduce risk of sexually transmitted diseases and discuss the practice of safe sex;
  4. List strategies on how to communicate information with other members of a patient's care team; and
  5. Discuss strategies to ensure a woman has adequate follow-up with a healthcare provider or referral as needed.

Module 4: Pharmacy Practice Operations

At the completion of this application-based activity, the learner should be able to:

  1. Discuss Maryland laws and regulations that allow pharmacists to prescribe hormonal contraceptives;
  2. Describe a process to prescribe hormonal contraceptives in pharmacy practice;
  3. Explain how to write a prescription for contraceptive products; and
  4. Document patient care visits, and the Maryland visit summary related to providing hormonal contraceptive products.

Your Instructors

Kristine Parbuoni, PharmD, BCPPS
Associate Professor, Department of Pharmacy, Practice and Science and Director of OSCE Programs
University of Maryland School of Pharmacy
 

Charmaine Rochester-Eyeguokan, PharmD, CDE, BCPS, BCACP
Professor, Department of Pharmacy, Practice and Science
Associate Director, Clinical Services, P3 eHealth Services
University of Maryland School of Pharmacy
 

Katherine Sánchez Vega, PharmD
Clinical Pharmacy Specialist, Women's Health
Veteran Affairs Maryland Health Care System

Technology Requirements

Unless otherwise noted in the course materials, the following are required to access online courses: A computer or mobile device with a stable internet connection; a current internet browser, such as Google Chrome, Microsoft Internet Explorer, Mozilla® Firefox, or Apple® Safari that supports the Adobe® Flash® Player; a PDF Viewer; and the ability to view and update Microsoft Word® and PowerPoint® documents.

Successful Completion:  Learners must complete all practice based activity components including the audiovisual presentations, post-tests, and activity evaluations. Participants must receive a score of at least 70% oneach of the post-test in order to receive credit. Each post-test may be taken up to three (3) times. Learners must complete the activity evaluation in order to receive CE credit. A link to the activity evaluation will be available once a learner has successfully completed all other course segments. Statements of CE Credit will be available electronically via CPE Monitor within sixty (60) days of completion of the activity.  

Privacy and Confidentiality: The University of Maryland School of Pharmacy is committed to protecting the privacy of our learners. All enrollees are protected under The Family Educational Rights and Privacy Act (20 U.S.C. § 1232g; 34 CFR Part 99) (FERPA). The UMB Policy on Confidentiality and Disclosure of Student Records can be found at: https://www.umaryland.edu/policies-and-procedures/library/academic-affairs/policies/iii-630a.php.   

In order to submit your continuing education credit record to National Association of Boards of Pharmacy (NABP) CPE Monitor, we must collect personal information including, but not limited to, name, NABP ID, and date of birth. Additionally, Maryland-licensed pharmacists seeking a Contraceptive Prescribing credential must allow for submission of their activity completion record to the Maryland Board of Pharmacy.

Copyright: Resources are provided for the educational benefit of our learners and are not for distribution. All information and materials provided are the property of and have been prepared by the University of Maryland Baltimore or have been granted permission for use by the copyright owner.  No portion of this module may be reproduced or transmitted without written permission.  All rights reserved.

Use of Trade Names:  The trade names of the drugs and delivery systems in this module are for the purpose of product identification only. This activity does not intend to imply endorsement for any commercial products discussed.

Conflict of Interest Disclosure: In accordance with ACPE’s Standards for Commercial Support, the faculty for this activity have disclosed no financial relationships with commercial interests.
 

The University of Maryland School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.



 

Refund Policy
  • A refund, less a $75 administration fee, will be made if cancellations are made within 15 days of purchase. Other restrictions may apply.
  • Refund requests must be submitted in writing to CEHelp@rx.umaryland.edu.
  • Refunds are not available in the following circumstances:
    • A learner has logged into a course or series;
    • A learner has launched course materials;
    • Course materials have been shipped; or
    • Request is made after 15 days of the ordering date.
  • Course registrations are non-transferrable.

Questions?  Review the Frequently Asked Questions page.  Can't find what you are looking for?  Contact Customer Service at CEHelp@rx.umaryland.edu or 410-706-3381.